+44(0)1284 765566
November 22, 2013

Instem Acquires Perceptive Instruments

Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it has acquired Perceptive Instruments as it continues to consolidate the life sciences IT marketplace.

Located in Suffolk, United Kingdom, Perceptive develops, manufactures and supplies image analysis and data processing solutions that are primarily focused on the areas of genetic toxicology, microbiology and immunology. Perceptive solutions are deployed in 49 countries at leading universities, research institutes and are supporting various government programs such as those at the National Center for Toxicological Research, a Food & Drug Administration division. Perceptive products also serve small and medium-sized companies along with many of today’s leading multinational organizations, including all of the top 10 pharmaceutical companies worldwide.

Operating as part of Instem, Perceptive Solutions include:

  • Comet Assay IV; live video-based system for scoring cells supporting DNA damage and repair studies and genetic toxicology testing
  • Ames Study Manager; comprehensive suite of software for conducting and reporting Ames studies in accordance with OECD 471
  • Cyto Study Manager; system for integrating all data acquisition, reporting and management during genetic toxicology investigations for individual and combined comet and micronucleus assays
  • Sorcerer Systems
    •  Colony Counter; combining image processing and analysis with an innovative Petri-viewer providing fast and accurate counts for bacterial and mammalian colonies for a wide range of applications
    • Image Analysis System; live video-based analytical tool for research and quality control
    • UDS; complete system for Unscheduled DNA Synthesis assays using live-video cell images and software for creating studies, randomization and slide scoring

Perceptive solutions are frequently referenced in scientific journals, during industry conferences and are featured in numerous case studies. All Perceptive products are designed to fulfil the requirements of Good Laboratory Practice, FDA 21 CFR Part 11 and other international regulatory guidelines. Perceptive remains one of a handful of image analysis & data processing companies worldwide whose management processes have been officially registered to ISO 9001:2008.

“The team here at Perceptive is excited and eager to join Instem,” states Colin White, Managing Director at Perceptive. “Various assays such as comet are playing an increasingly important role in the drug development process. Instem’s leadership position will allow us to further our mission of providing quality solutions and excellent after-sales service to a growing set of clients.”

“This acquisition is another win for our market,” comments Phil Reason, CEO at Instem. “Our clients will now have the ability to turn to one global supplier for their data management needs across broader segments, providing them with greater efficiencies. Many of the tests Perceptive products support are a required part of the regulated study process and our commanding position across early development will enable us to help users better collect, manage, review and extract data while transitioning information into valuable insight.”

As part of the Instem group, the staff at Perceptive will now have access to additional capabilities in marketing, sales, management and software development. Current Perceptive clients can also expect additional regional support services before and after purchasing a solution from Instem offices around the globe.

Perceptive solutions will enhance Instem’s Study Workflow and Automation Suite, enabling organizations of all sizes to collect, manage, review and submit study data that streamline processes, increase quality and enhance development programs.

Instem has been developing, releasing and introducing a stream of technology solutions to the market as part of their mission to deliver compelling solutions for data collection, management and analysis across the R&D continuum. Earlier this year Instem entered the early phase Clinical Market through another strategic acquisition and is planning to remain active in expanding the reach of its product portfolio into related scientific domains.

About Instem 

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processeswhile offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports its clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

To learn more about Instem solutions and its mission, please visit www.instem.com.